EGFRvIII TandAbs are specific and highly potent drug...

Journal for ImmunoTherapy of Cancer 2015 Vol. 3; Iss. Suppl 2

EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors

Ellwanger, Kristina, Reusch, Uwe, Fucek, Ivica, Weichel, Michael, Gantke, Thorsten, Knackmuss, Stefan, Molkenthin, Vera, Marschner, Jens-Peter, Treder, Martin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P219
File:
PDF, 250 KB
english, 2015
Conversion to is in progress
Conversion to is failed